Every Drug Enforcement Administration Federal Register document since 1994 — Controlled Substances Act scheduling decisions (CUMYL-PEGACLONE Schedule I 2026, hexahydrocannabinol 2026), bulk manufacturer registrations, importer/exporter applications, aggregate production quotas, and most importantly **1,232 Decision-and-Order enforcement revocations** against pharmacies, physicians, and distributors who violated controlled-substance regulations (Pine Pharmacy 2026, Hovic Pharmacy 2025, John Bender M.D. 2026). Categorized as enforcement / scheduling / quota / application / hearing / other. Source: `federalregister.gov/api/v1/documents.json` (public JSON API, no auth). Distinct from HHS-OIG enforcement (healthcare fraud), IRS-CI (tax/PPP fraud) — this is DEA-specific controlled-substance regulation.
Every record in this dataset can be traced back to its primary source at https://www.federalregister.gov/agencies/drug-enforcement-administration. Underlying content is a US federal government work (public domain under 17 USC §105); our derived data is licensed CC0 1.0.